Mikio Nishizawa Selected Research

Mikio Nishizawa Research Topics

Disease

13	Inflammation (Inflammations) 01/2024 - 01/2002
10	Wounds and Injuries (Trauma) 01/2017 - 02/2008
6	Reperfusion Injury 05/2024 - 02/2008
6	Neoplasms (Cancer) 12/2020 - 04/2003
5	Ischemia 05/2024 - 09/2008
5	Hepatocellular Carcinoma (Hepatoma) 04/2015 - 04/2003
4	Acute Liver Failure (Fulminant Hepatic Failure) 10/2019 - 02/2008
4	Fibrosis (Cirrhosis) 01/2016 - 07/2007
3	Sepsis (Septicemia) 01/2023 - 01/2018
3	Septic Shock (Toxic Shock Syndrome) 01/2023 - 06/2002
3	Liver Diseases (Liver Disease) 09/2013 - 02/2008
3	Pain (Aches) 06/2004 - 01/2002
3	Hyperalgesia 06/2004 - 01/2002
2	Jaundice (Icterus) 05/2024 - 01/2012
2	Dermatitis 09/2023 - 10/2017
2	Eczema 09/2023 - 01/2020
2	Hypoxia (Hypoxemia) 09/2023 - 04/2004
2	Type 2 Diabetes Mellitus (MODY) 04/2023 - 06/2020
2	Insulin Resistance 04/2023 - 01/2022
2	Carcinogenesis 12/2020 - 11/2002
2	Body Weight (Weight, Body) 06/2020 - 04/2020
2	Hemorrhage 04/2020 - 01/2020
2	Ulcerative Colitis 04/2020 - 09/2014
2	Colitis 04/2020 - 09/2014
2	Edema (Dropsy) 01/2020 - 01/2002
2	Ulcer 01/2020 - 07/2015
2	Necrosis 01/2020 - 01/2019
2	Stomach Ulcer (Gastric Ulcer) 10/2017 - 02/2008
2	Infections 04/2013 - 07/2007
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2012 - 07/2007
1	Hypertrophy 05/2024
1	Hepatitis 05/2024
1	Anemia 09/2023
1	Headache (Headaches) 06/2023
1	Fever (Fevers) 06/2023
1	Cough 06/2023
1	Insulinoma 01/2022
1	Triple Negative Breast Neoplasms 12/2020
1	Adenocarcinoma 12/2020
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Hyperglycemia 06/2020
1	Diarrhea 04/2020
1	Weight Loss (Weight Reduction) 04/2020
1	Rhinitis 01/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020
1	Urticaria (Hives) 01/2020

Drug/Important Bio-Agent (IBA)

12	Messenger RNA (mRNA)IBA 01/2024 - 01/2002
7	CytokinesIBA 01/2024 - 07/2007
6	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2024 - 02/2008
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 06/2002
3	OligonucleotidesIBA 01/2023 - 04/2013
3	NF-kappa B (NF-kB)IBA 10/2019 - 02/2008
2	ChemokinesIBA 01/2024 - 10/2019
2	Antitussive Agents (Antitussives)FDA Link 06/2023 - 07/2015
2	Insulin (Novolin)FDA Link 04/2023 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 04/2023 - 06/2020
2	jumi-haidoku-toIBA 01/2020 - 03/2019
2	Active Hexose Correlated CompoundIBA 11/2019 - 08/2014
2	Analgesics (Analgesic Drugs)IBA 01/2015 - 04/2005
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 11/2002
2	Fluvastatin FDA Link 09/2014 - 07/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2013 - 02/2008
2	EdaravoneIBA 12/2008 - 03/2008
2	N-Methylaspartate (NMDA)IBA 06/2008 - 06/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 07/2007 - 04/2003
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2004 - 07/2003
1	baicaleinIBA 05/2024
1	EnzymesIBA 05/2024
1	FlavonoidsIBA 05/2024
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2024
1	LigandsIBA 01/2024
1	Interleukin-10 (Interleukin 10)IBA 01/2024
1	Transaminases (Aminotransferases)IBA 01/2024
1	sulforaphaneIBA 01/2024
1	roxadustatIBA 09/2023
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 09/2023
1	Expectorants (Mucolytics)IBA 06/2023
1	Pyruvic Acid (Pyruvate)IBA 04/2023
1	ThrombomodulinIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2022
1	EphrinsIBA 12/2020
1	EphA2 ReceptorIBA 12/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2020
1	Antisense RNA (Anti-Sense RNA)IBA 12/2020
1	Long Noncoding RNAIBA 12/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2020
1	SaltsIBA 04/2020
1	Indigo Carmine (Indigo Blue)IBA 04/2020
1	Dextran SulfateIBA 04/2020
1	Qingdai compoundIBA 04/2020
1	Methanol (Carbinol)IBA 04/2020
1	3-N-butyl-4,5-dihydrophthalide (NBPA)IBA 01/2020
1	atractylodinIBA 01/2020

Therapy/Procedure

11	Kampo Medicine (Kampo) 05/2024 - 01/2012
4	Hepatectomy 05/2024 - 01/2023
2	Therapeutics 01/2023 - 04/2015
2	Oral Administration 04/2020 - 09/2014
1	Warm Ischemia 01/2024
1	bitter melon extract 06/2020